Hyundai Bioscience innovates multi-treatment drug for mosquito-borne viral infections
Hyundai Bioscience, under the leadership of CEO Oh Sang-gi, has announced a significant breakthrough in the fight against mosquito-borne diseases. The company has developed a multi-treatment drug utilizing niclosamide as the primary active ingredient, effective against a range of viruses including dengue, Zika, Chikungunya, and Yellow Fever. This development comes as Hyundai prepares for a […]